New published research paper: “Biobran/MGN-3, an Arabinoxylan Rice Bran, Protects against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An In Vitro and In Silico Study”/Daiwa Pharmaceutical Co.,Ltd./English

HOME　>　News　>　News Release　>　New published research paper: “Biobran/MGN-3, an Arabinoxylan Rice Bran, Protects against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An In Vitro and In Silico Study”

Feb. 2023

New published research paper: “Biobran/MGN-3, an Arabinoxylan Rice Bran, Protects against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An In Vitro and In Silico Study”

A research group at Pharos University of Alexandria (Egypt) and Drew University of Medicine and Science (USA) published a study on BioBran, titled “Biobran/MGN-3, an Arabinoxylan Rice Bran, Protects against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An In Vitro and In Silico Study”

This study was published in Nutrients 2023, 15, 453.
Authors: Mamdooh Ghoneum, Shaymaa Abdulmalek and Hewida H. Fadel

｜　◀ Previous　｜　Index　｜　Next ▶　｜